A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Clinical trial NCT05595642 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05595642
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-29
- Primary completion
- 2025-06-24
- Enrollment
- 1290
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.